Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anna J M van de Sande"'
Autor:
Natasja Hendriks, Sjoerd H van der Burg, Ziena Abdulrahman, Noel F C C de Miranda, Edith M G van Esch, Peggy J de Vos van Steenwijk, Antonios Somarakis, Arnold J Kruse, Anna J M van de Sande, Heleen J van Beekhuizen, Jurgen M J Piek, Loes F S Kooreman, Brigitte F M Slangen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 11 (2022)
Background The complete response rate of cervical high-grade squamous intraepithelial lesion (cHSIL) patients to imiquimod immunotherapy is approximately 60%. Consequently, many patients are exposed to unnecessary adverse effects of imiquimod. On the
Externí odkaz:
https://doaj.org/article/ae2985823b1043c281f9a4695715eadb
Autor:
Anna J. M. van de Sande, Coen M. Schreuder, Romy van Baars, Margot M. Koeneman, Cornelis G. Gerestein, Arnold-Jan Kruse, Folkert J. van Kemenade, Sten P. Willemsen, Heleen J. van Beekhuizen
Publikováno v:
Obstetrics and Gynecology, 139(3), 417-422. Lippincott Williams & Wilkins
Obstetrics and Gynecology, 139(3), 417-422. LIPPINCOTT WILLIAMS & WILKINS
Obstetrics and Gynecology, 139(3), 417-422. LIPPINCOTT WILLIAMS & WILKINS
OBJECTIVE: To evaluate the efficacy and long-term outcome of repeat large loop excision of the transformation zone in women with residual or recurrent cervical intraepithelial neoplasia.METHODS: PALGA (the Dutch Pathology Registry), a database of dei
Autor:
Ziena Abdulrahman, Natasja Hendriks, Arnold J Kruse, Antonios Somarakis, Anna J M van de Sande, Heleen J van Beekhuizen, Jurgen M J Piek, Noel F C C de Miranda, Loes F S Kooreman, Brigitte F M Slangen, Sjoerd H van der Burg, Peggy J de Vos van Steenwijk, Edith M G van Esch
Publikováno v:
Journal for ImmunoTherapy of Cancer, 10(11). BMJ PUBLISHING GROUP
Journal for ImmunoTherapy of Cancer, 10(11):e005288. BioMed Central Ltd
Journal for ImmunoTherapy of Cancer, 10(11):e005288. BioMed Central Ltd.
Journal for ImmunoTherapy of Cancer, 10(11):e005288. BioMed Central Ltd
Journal for ImmunoTherapy of Cancer, 10(11):e005288. BioMed Central Ltd.
BackgroundThe complete response rate of cervical high-grade squamous intraepithelial lesion (cHSIL) patients to imiquimod immunotherapy is approximately 60%. Consequently, many patients are exposed to unnecessary adverse effects of imiquimod. On the
Autor:
Anna J M, van de Sande, Coen M, Schreuder, Romy, van Baars, Margot M, Koeneman, Cornelis G, Gerestein, Arnold-Jan, Kruse, Folkert J, van Kemenade, Sten P, Willemsen, Heleen J, van Beekhuizen
Publikováno v:
Obstetrics and gynecology. 139(3)
To evaluate the efficacy and long-term outcome of repeat large loop excision of the transformation zone in women with residual or recurrent cervical intraepithelial neoplasia.PALGA (the Dutch Pathology Registry), a database of deidentified cervical c
Autor:
Margot M. Koeneman, Rafli van de Laar, Arnold-Jan Kruse, Heleen J. van Beekhuizen, Roy F.P.M. Kruitwagen, Anna J. M. van de Sande, Kees G. Gerestein
Publikováno v:
Journal of Lower Genital Tract Disease, 20(1), 75-79. LIPPINCOTT WILLIAMS & WILKINS
Journal of Lower Genital Tract Disease, 20(1), 75-79. Lippincott Williams & Wilkins
Journal of Lower Genital Tract Disease, 20(1), 75-79. Lippincott Williams & Wilkins
Objective The aim of the study was to assess awareness, attitudes, and current clinical experiences of gynecologists regarding imiquimod as a potential treatment modality for vaginal intraepithelial neoplasia (VAIN) and cervical intraepithelial neopl
Autor:
Dieuwke Boskamp, Carmen D. Dirksen, Arnold J. Kruse, Brigitte A. B. Essers, Cornelis G. Gerestein, Anna J. M. van de Sande, Rogier J.N.T.M. Litjens, Heleen J. Beekhuizen, Roy F.P.M. Kruitwagen, Margot M. Koeneman, Medi F.J. Goossens
Publikováno v:
Journal of Immunotherapy, 40(4), 148-153. LIPPINCOTT WILLIAMS & WILKINS
Journal of Immunotherapy, 40(4), 148-153. Lippincott Williams & Wilkins
Journal of Immunotherapy, 40(4), 148-153. Lippincott Williams & Wilkins
Imiquimod has been studied as a noninvasive pharmacological treatment alternative to large loop excision of the transformation zone (LLETZ) for high-grade cervical intraepithelial neoplasia (CIN), to prevent long-term obstetric complications from sur